Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India

Journal of Postgraduate Medicine

Volumn 59, Issue 3, 2013, Pages 226-228

  Das, V N R ^a   Pandey, K ^a   Singh, D ^a   Forwood, C ^b   Lal, C S ^a   Das, P ^a  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

AmBisome; kala azar; post kala azar dermal leishmaniasis; visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPOPIGMENTATION; IMMUNOAFFINITY CHROMATOGRAPHY; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS RAPID TEST; MALE; POLYMERASE CHAIN REACTION; POST KALA AZAR DERMAL LEISHMANIASIS; SKIN LEISHMANIASIS; SKIN MANIFESTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; DISEASE RESERVOIRS; FEMALE; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE;

EID: 84884667899     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.118046     Document Type: Article

References (10)

1. Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Post kala-Azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 2001;95:S59-76
2. Dutta M, Ghosh TK. Review of current status of Leishmaniasis epidemiology. In: The Indo-UK Workshop on leishmaniasis. New Delhi: Indian Council of medical research; 1983. p. 97-102
3. World Health Organization (WHO). Disease control a decade of health development in South-East Asia 1968-1977. South-East Asia regional publication series No. 7. New Delhi: WHO; 1978. p. 233
4. Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, et al. Impact of amphotericin-B in the treatment of kala-Azar on the incidence of PKDL in Bihar, India. Indian J Med Res 2008;128:38-44
5. Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, et al. Short report: Development of post-kala-Azar dermal leishmaniasis (PKDL) in miltefosine-Treated visceral leishmaniasis. Am J Trop Med Hyg 2009;80:336-8
6. Khalil EA, Hashim FA, Ali MS, Ghalib HW, Zijlstra EE, El Hag IA, et al. Comparative study of liposomal amphotericin B (AmBisome) and sodium stibogluconate in the treatment of Kala-Azar in the Sudan. E Afr Med J 1998;75:481-4
7. Sharma MC, Gupta AK, Verma N, Das VN, Saran R, Kar SK. Demonstration of Leishmania parasites in skin lesions of Indian post kala-Azar dermal leishmaniasis (PKDL) cases. J Commun Dis 2000;32:67-8
8. Salotra P, Singh R. Challenges in the diagnosis of post kala-Azar dermal leishmaniasis. Indian J Med Res 2006;123:295-310
9. Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, et al. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Natl Med J India 2005;18:131-3
10. Thakur CP, Narain S, Kumar N, Hassan SM, Jha DK, Kumar A. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-Azar dermal leishmaniasis. Ann Trop Med Parasitol 1997;91:611-6